APLLTD Intraday Analysis...

APLLTD Share Price

Open 625.00 Change Price %
High 625.00 1 Day -2.15 -0.35
Low 607.90 1 Week 4.25 0.70
Close 612.35 1 Month 19.55 3.30
Volume 17648 1 Year 1.30 0.21
52 Week High 699.00
52 Week Low 514.60
APLLTD Important Levels
Resistance 2 628.20
Resistance 1 621.67
Pivot 615.08
Support 1 603.03
Support 2 596.50
NSE INDIA Most Active Stocks
FEDERALBNK 107.60 14.04%
IFCI 31.70 8.93%
SOUTHBANK 25.70 4.47%
ADANIENT 108.95 -4.56%
JPASSOCIAT 13.65 0.74%
IBREALEST 149.85 -4.13%
SUZLON 20.60 0.49%
JINDALSTEL 114.00 0.22%
IDFCBANK 65.75 0.84%
GMRINFRA 17.25 -1.71%
More..
NSE INDIA Top Gainers Stocks
KSERASERA 0.20 33.33%
VISESHINFO 0.20 33.33%
AUSTRAL 0.30 20.00%
DHUNINV 244.50 20.00%
TFL 13.85 19.91%
TTML 8.25 19.57%
AMTEKAUTO 39.30 18.37%
FEDERALBNK 107.60 14.04%
CASTEXTECH 8.85 13.46%
FACT 52.80 10.58%
More..
NSE INDIA Top Losers Stocks
GAL 10.05 -19.92%
GAL 10.05 -19.92%
GAL 10.05 -19.92%
SRGINFOTEC 0.30 -14.29%
SHARONBIO 6.45 -10.42%
MVL 0.45 -10.00%
MVL 0.45 -10.00%
SHILPI 119.50 -9.98%
RKDL 13.20 -9.90%
SUPPETRO 391.85 -8.63%
More..

Alembic Pharmaceuticals Limited (NSE: APLLTD)

APLLTD Technical Analysis 3
As on 28th Apr 2017 APLLTD Share Price closed @ 612.35 and we RECOMMEND Buy for LONG-TERM with Stoploss of 609.84 & Buy for SHORT-TERM with Stoploss of 596.44 we also expect STOCK to react on Following IMPORTANT LEVELS.
APLLTD Target for April
1st Target up-side 672.9
2nd Target up-side 704.76
3rd Target up-side 736.62
1st Target down-side 582
2nd Target down-side 550.14
3rd Target down-side 518.28
APLLTD Synopsis Technicals View
50 Day EMA Close is Above EMA 50 (Short Term)
Bullish
100 Day EMA Close is Above EMA 100 (Mid Term) Bullish
200 Day EMA Close is Above EMA 200 (Long Term) Bullish
MACD (12 26 9) MACD Line is Less Then SIGNAL Line Bearish
RSI (14) RSI is 50.92 Sideways
MFI (14) MFI is 32.91 Sideways
CCI (20) CCI is -38.36 Sideways
WILLIAM %R (14) William %R is -74.56 Sideways
ADX (14) ADX is Above 20 & +DI is Above -DI Up Trend
PSAR Stoploss For Short Sell 635.56
10 Day Avg Volume Traded -75.97 % Less then 10 Day Average Volume
APLLTD Other Details
Segment EQ
Market Capital 0.00
Sector Pharmaceuticals
Industry
Offical website
APLLTD Address
APLLTD
N/A
APLLTD Latest News
Alembic Pharma - Q3 results on Feb 04, 2015   Moneycontrol.com   - 23rd Jan 15
Alembic Pharma buying 49% stake in Algerian drugmaker Adwiya Mami   VC Circle   - 27th Oct 14
Alembic Pharma, Hester Biosciences net profit jumps 25%, 66% respectively   Economic Times   - 21st Oct 14
Alembic Pharma Q2 net up 54%   Business Standard   - 25th Oct 13
Alembic Pharma's net profit 27 pc up; to abandon low margin API & formulation   Economic Times   - 02nd May 13
Alembic Pharma to focus on regulated markets   Business Standard   - 21st Jan 13
Alembic Pharma will add more specialty product, Q2 net profit up 12%   Economic Times   - 19th Oct 12
Alembic Pharma - Fire at API 1 plant at Panelav, Gujarat   Moneycontrol.com   - 27th Aug 12
Alembic Pharma   Moneycontrol.com   - 20th Sep 11
Alembic Pharma sales up 34%, plans Brazil foray   Economic Times   - 27th Jul 11
Interactive Technical Analysis Chart Alembic Pharmaceuticals Limited ( APLLTD NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Alembic Pharmaceuticals Limited
APLLTD Business Profile
Alembic Pharma is in the Pharmaceuticals sector. It is established in 1907, Alembic Pharmaceuticals Limited is a leading pharmaceutical company in India. The Company is vertically integrated with the ability to develop, manufacture and market pharmaceutical products, pharmaceutical substances and Intermediates. Alembic is the market leader in the Macrolides segment of anti-infective drugs in India. Alembic's manufacturing facilities are located in Vadodara and Baddi in Himachal Pradesh. The plant at Vadodara has the largest fermentation capacity in India. The Panelav facility houses the API and formulation manufacturing (both US FDA approved) plants. The plant at Baddi, Himachal Pradesh manufactures formulations for the domestic and non-regulated export market. The company has a state of the art Research Centre at Vadodara. The current market capitalisation stands at Rs 3,760.89 crore.The company has reported a consolidated sales of Rs 484.28 crore and a Net Profit of Rs 61.64 crore for the quarter ended Sep 2013. The company management includes Chirayu R Amin - Chairman & Managing Director, K G Ramanathan - Director, Paresh Saraiya - Director, Pranav N Parikh - Director, Milin Mehta - Director, Pranav Amin - President & Director, Shaunak Amin - President & Director, R K Baheti - Dir-President & Com.Secretary. It is listed on the BSE with a BSE Code of 533573 and the NSE with an NSE Code of APLLTD. Its Head office is at Alembic Road , Vadodra,Gujarat - 390003.